BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 33935036)

  • 1. Myelodysplastic syndromes and overlap syndromes.
    Chang YH
    Blood Res; 2021 Apr; 56(S1):S51-S64. PubMed ID: 33935036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDS overlap disorders and diagnostic boundaries.
    Tanaka TN; Bejar R
    Blood; 2019 Mar; 133(10):1086-1095. PubMed ID: 30670443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Navigating Myelodysplastic and Myelodysplastic/Myeloproliferative Overlap Syndromes.
    Hasserjian RP; Buckstein R; Patnaik MM
    Am Soc Clin Oncol Educ Book; 2021 Mar; 41():328-350. PubMed ID: 34010050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders - Epidemiological Features and Overview.
    Kuendgen A; Kasprzak A; Germing U
    Front Oncol; 2021; 11():778741. PubMed ID: 34869027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelodysplastic/myeloproliferative neoplasms: are morphology and immunophenotyping still relevant?
    Sangiorgio VFI; Orazi A; Arber DA
    Best Pract Res Clin Haematol; 2020 Jun; 33(2):101139. PubMed ID: 32460987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Pathogenesis and Treatment of Myelodysplastic Syndromes.
    Nakajima H
    Intern Med; 2021 Jan; 60(1):15-23. PubMed ID: 32009100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genomic aberrations in myelodysplastic syndromes and related disorders].
    Makishima H
    Rinsho Ketsueki; 2019; 60(6):600-609. PubMed ID: 31281151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traipsing Through Muddy Waters: A Critical Review of the Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) Overlap Syndromes.
    Kuykendall AT; Tokumori FC; Komrokji RS
    Hematol Oncol Clin North Am; 2021 Apr; 35(2):337-352. PubMed ID: 33641873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromes.
    Tiu RV; Sekeres MA
    Curr Opin Hematol; 2014 Mar; 21(2):131-40. PubMed ID: 24378705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current approach to the diagnosis of myelodysplastic syndromes
    Weinberg OK; Hasserjian RP
    Semin Hematol; 2019 Jan; 56(1):15-21. PubMed ID: 30573039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic syndromes: the pediatric point of view.
    Locatelli F; Zecca M; Pession A; Maserati E; De Stefano P; Severi F
    Haematologica; 1995; 80(3):268-79. PubMed ID: 7672722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.
    Patnaik MM; Lasho TL
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):450-459. PubMed ID: 33275756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current perspective of low-grade myelodysplastic syndrome in children.
    Hasegawa D
    Int J Hematol; 2016 Apr; 103(4):360-4. PubMed ID: 26939774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplastic and myeloproliferative neoplasms: updates on the overlap syndromes.
    Thota S; Gerds AT
    Leuk Lymphoma; 2018 Apr; 59(4):803-812. PubMed ID: 28771058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive therapy for myelodysplastic syndromes.
    Dobbelstein C; Ganser A
    Curr Pharm Des; 2012; 18(22):3184-9. PubMed ID: 22571697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in myelodysplastic syndromes: Core abnormalities and CHIPping away at the edges.
    Caponetti GC; Bagg A
    Int J Lab Hematol; 2020 Dec; 42(6):671-684. PubMed ID: 32757473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
    Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
    Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms.
    Palomo L; Acha P; Solé F
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33925681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelodysplastic/myeloproliferative neoplasms.
    Hyjek E; Vardiman JW
    Semin Diagn Pathol; 2011 Nov; 28(4):283-97. PubMed ID: 22195406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.